Your success is our success: stories from TIDES attendees
“Key player in CDMO for peptides, TIDES is the best playground for visibility, contact and knowledge sharing” – Fabien Rousset, Innovation Director at PolyPeptide Group
“TIDES is the one meeting I can count on to give me a complete overview of where the oligonucleotide market is heading.” – Kathryn Ackley, CMC Consultant
We like to think of TIDES as the event that brings together new and old faces, that opens doors for novel research and opportunities, and that offers a breadth of relevant topics from the oligonucleotide and peptide industry for various professionals, from R&D scientists and CMC specialists to business development executives and academic researchers.
However, we can be a little biased and our event experience a little different to yours – yes, that’s us, running around with a phone, coffee, camera, and tape measure in hand.
That’s why we have collected our delegates’ and speakers’ stories about TIDES: the friendships they made on the exhibition hall, the research they developed thanks to conversations with partners in our meeting rooms, and the sessions that inspired or enlightened them.
Discover what our attendees have to say about why you should come to TIDES too.
“Of course, the main reason for attending TIDES is networking and learning about new developments and innovations. Besides this, a TIDES attendance presents additional benefits like:
Meeting old friends and work colleagues from previous engagements.
Meeting the established and new service providers in the field.
Learning about new equipment and technologies.
Exchanging experiences and ideas with people who share the same passion and struggle with the same issues.
Getting away from work with the opportunity to socialize and recover with minimal disturbances.
Meeting everyone at one place without wasting a lot of travel and work time.” - Pius Bar, Scientific Director, JNJ Innovative Medicine
Pius summarised very well what TIDES is all about, but if you are thinking of attending for a specific reason such as networking, check out how TIDES helped other attendees with the same issue.
If you are looking for...
New ideas and technologies
“TIDES has been responsible for driving innovative manufacturing approaches to oligonucleotides. In particular, enzyme technologies. This is resulting in a breakthrough in investment to produce ton scales, previously not possible with solid phase synthesis” - Mike Webb PhD, MikeWebbPharma Ltd
“TIDES brings discovery and development together across oligonucleotides, mRNA and peptides in a way that is particularly valuable for those of us working in CMC. Exposure to emerging molecules, new chemical modifications and delivery approaches gives me an early view of the innovations that may soon enter development and challenges me to think ahead about the CMC and regulatory strategies they will require. It helps me anticipate what is coming, stay ahead of the curve, and move with greater speed and confidence as novel modalities progress toward later-stage development.” - Nadya Brady, Founder of LuminaBio Advisory
“TIDES provides a good mix of business and science and excellent networking opportunities within the growing TIDES community. We are looking forward to having TIDES as launch event for a new Product.” - Thomas Müller-Späth, CEO at ChromaCon
Connections with industry leaders
“Beyond the high scientific quality of the presentations, the conference has provided an excellent opportunity to establish new connections with technology providers and potential development partners in the oligonucleotide field. The discussions we had during the event have already led to several follow-up meetings, and we are currently exploring potential collaborations related to oligonucleotide manufacturing technologies and future product development.” - Ömer Faruk Fırat, R&D Director, Polifarma
“The conference is also a valuable networking platform where I have built new relationships, exchanged ideas with peers, and gained insights that have helped shape innovation and technology strategies within my organization.” - Olivier Ludemann-Hombourger, Director Global, Innovation & Technology at Polypeptide Laboratories France S.A.S
“I have been attending TIDES in Europe and the US for 15 years. The opportunity to network, talk to CDMO’s, academics and clients is unparalleled” - Mike Webb PhD, Founder and CEO of MikeWebbPharma Ltd
“I had the opportunity to explore relationships with leading CROs, meet high-level scientists and industry experts, and initiate discussions that could potentially lead to strategic partnerships. These connections and conversations are extremely valuable, particularly when you are developing and introducing a new technology.” - David R. Tabatadze, Ph.D., President and CEO at ZATA Pharmaceuticals, Inc.
“At my first TIDES, I met new collaborators and interacted with old contacts. Now, we are in discussions with two Pharma companies.” - Yana Reshetnyak, CEO and Co-Founder at pHLIP Inc
“I attend TIDES because I know I'm going to meet lots of the key people and companies in the space, hear great talks, and come away with new ideas.” – Arthur Krieg, Founder, President, and acting CEO/CSO at Zola Therapeutics
The latest industry trends and insights
“I have found TIDES to be an excellent forum for learning about the latest advances in oligonucleotide therapeutics and related technologies. The meetings consistently bring together experts from academia and industry, providing valuable scientific insights as well as perspectives on translation and application.” – Afaf El-Sagheer, Research Fellow at Oxford University
“TIDES has consistently been a key annual event for the peptide and oligonucleotide community. I keep attending because it provides an excellent opportunity to follow market trends, identify emerging concepts and technologies, and connect with industry leaders.” - Olivier Ludemann-Hombourger, Director Global, Innovation & Technology at Polypeptide Laboratories France S.A.S
“I gain insights into the latest developments in the peptide and oligonucleotide fields. I particularly appreciate the broad coverage of TIDES, from discovery and development through manufacturing and regulatory aspects.” - Kosh Neupane, PhD, Associate Director, CMC at AvidityBio
“As a recurring session chairman at TIDES Europe, I’ve found the conference invaluable. The quality of the presentations gave me great cross-functional insights to bring back home, and the networking opportunities are second to none. Fantastic organization, great venues, and a wonderful atmosphere every time!” - Daniel Waschke, Dr. Regulatory Program Director at La Roche Ltd.
“As always, it was a great opportunity to reconnect with old colleagues, establish new relationships, and of course hear the newest updates across the broad spectrum of oligonucleotide and peptide technologies and the latest clinical advances.” – Steven K Wolk, Founder, Sinawali Biotechnology Solutions
or maybe you want...
The whole world in one venue
“At TIDES you meet people from Asia in EU, people from US in Asia, and EU people in US. This melting pot of culture and science is very important to build strong relationship vs cultural silos.” - Fabien Rousset, Innovation Director at PolyPeptide Group
“The TIDES conference is a must attend event for anyone working in the oligo drug development space. Nowhere else is there such a large convergence of scientists, drug sponsors, CDMOs, raw material suppliers, and equipment manufacturers. No other conference can reproduce the scale and scope of the TIDES conference.” – Kathryn Ackley, CMC Consultant
Ways to propel your research
“TIDES provides a rare opportunity to interact directly with leading experts in the field. When you are developing a new technology, the reactions and feedback you receive from these experts can provide valuable validation of your platform. If respected leaders in the field understand what you are proposing, become interested, and see its potential, that is one of the strongest forms of validation you can receive.” - David R. Tabatadze, Ph.D., President and CEO at ZATA Pharmaceuticals, Inc.
TIDES Europe 2026 is a premier event for oligonucleotide and peptide therapeutics with over 100 speaker presentations full of practical insights and multiple case studies from oligonucleotide, peptide, mRNA, Genome Editing and Macromolecular delivery and discovery/preclinical/clinical and CMC programs. Don’t miss out on “one of the most relevant and impactful events in the field, bringing together science, technology, and business in a unique way” (Olivier’s words, Director Global, Innovation & Technology at Polypeptide Laboratories France S.A.S, not ours!). Register here.